ATE417106T1 - Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon - Google Patents
Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davonInfo
- Publication number
- ATE417106T1 ATE417106T1 AT00908862T AT00908862T ATE417106T1 AT E417106 T1 ATE417106 T1 AT E417106T1 AT 00908862 T AT00908862 T AT 00908862T AT 00908862 T AT00908862 T AT 00908862T AT E417106 T1 ATE417106 T1 AT E417106T1
- Authority
- AT
- Austria
- Prior art keywords
- dna fragments
- chlamydia
- corresponding dna
- strain
- host
- Prior art date
Links
- 241000606161 Chlamydia Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 241001647372 Chlamydia pneumoniae Species 0.000 abstract 2
- 108010052285 Membrane Proteins Proteins 0.000 abstract 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 2
- 235000018417 cysteine Nutrition 0.000 abstract 2
- -1 DNA Chemical class 0.000 abstract 1
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12396699P | 1999-03-12 | 1999-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE417106T1 true ATE417106T1 (de) | 2008-12-15 |
Family
ID=22411985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00908862T ATE417106T1 (de) | 1999-03-12 | 2000-03-09 | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US7183402B2 (de) |
| EP (2) | EP2172214A3 (de) |
| JP (1) | JP4832646B2 (de) |
| AT (1) | ATE417106T1 (de) |
| AU (1) | AU775695B2 (de) |
| CA (1) | CA2365196C (de) |
| DE (1) | DE60041042D1 (de) |
| MX (1) | MXPA01009256A (de) |
| NZ (1) | NZ514140A (de) |
| WO (1) | WO2000055326A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9513371D0 (en) * | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
| MXPA01005615A (es) * | 1998-12-04 | 2004-08-19 | Univ Manitoba | Procedimiento de inmunizacion en dos pasos para proteger contra infeccion por chlamydia. |
| US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| WO2001036456A2 (en) * | 1999-11-15 | 2001-05-25 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| EP1240331B1 (de) * | 1999-12-22 | 2010-04-07 | Aventis Pasteur Limited | Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen |
| GB0227346D0 (en) * | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| JP5942296B2 (ja) * | 2010-03-29 | 2016-06-29 | サントル・ナショナル・ドゥ・ラ・ルシェルシュ・シャンティフィクCentre National De La Recherche Scientifique | 少なくとも1つのcxxcモチーフを含むポリペプチドと異種抗原とを含む医薬組成物、及びその使用 |
| CN102859816B (zh) * | 2010-04-02 | 2014-11-12 | 日本特殊陶业株式会社 | 火花塞 |
| CA3004924A1 (en) | 2015-11-10 | 2017-05-18 | Ohio State Innovation Foundation | Methods and compositions related to accelerated humoral affinity |
| US11185555B2 (en) | 2016-04-11 | 2021-11-30 | Noah James Harrison | Method to kill pathogenic microbes in a patient |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879213A (en) | 1986-12-05 | 1989-11-07 | Scripps Clinic And Research Foundation | Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse |
| US5837268A (en) * | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
| US5776746A (en) | 1996-05-01 | 1998-07-07 | Genitope Corporation | Gene amplification methods |
| US6210876B1 (en) * | 1996-06-06 | 2001-04-03 | Abbott Laboratories | Nucleic acid primers and probes for detecting Chlamydia pneumoniae |
| US20020044949A1 (en) * | 1997-04-01 | 2002-04-18 | Harold Kleanthous | 76 kda helicobacter polypeptides and corresponding polynucleotide molecules |
| US6020191A (en) | 1997-04-14 | 2000-02-01 | Genzyme Corporation | Adenoviral vectors capable of facilitating increased persistence of transgene expression |
| ES2264810T3 (es) * | 1997-06-23 | 2007-01-16 | Loke Diagnostics Aps | Proteinas de chlamydia pneumoniae expuestas en la superficie. |
| KR20010032336A (ko) | 1997-11-21 | 2001-04-16 | 브랑디 빠스깔 | 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
| ATE480625T1 (de) | 1997-11-21 | 2010-09-15 | Merck Serono Biodevelopment | Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion |
| KR100760221B1 (ko) | 1997-11-28 | 2007-10-30 | 세로노 제네틱스 인스티튜트 에스.에이. | 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
| US6693087B1 (en) | 1998-08-20 | 2004-02-17 | Aventis Pasteur Limited | Nucleic acid molecules encoding POMP91A protein of Chlamydia |
| AU5366099A (en) | 1998-08-20 | 2000-03-14 | Connaught Laboratories Limited | Nucleic acid molecules encoding inclusion membrane protein of (chlamydia) |
| JP2002525078A (ja) | 1998-09-15 | 2002-08-13 | イェール ユニバーシティ | 人工的長末端反復配列 |
| EP1129202A2 (de) | 1998-10-28 | 2001-09-05 | Aventis Pasteur Limited | Chlamydia polypeptiden und entspechende dna fragmenten und anwendungen davon |
| EP1133572A4 (de) | 1998-11-12 | 2005-06-15 | Univ California | Genomsequenz von chlamydia pneumoniae |
| US6822071B1 (en) | 1998-11-12 | 2004-11-23 | The Regents Of The University Of California | Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease |
| AU3790900A (en) | 1998-12-01 | 2000-06-19 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| CN100365120C (zh) | 1998-12-08 | 2008-01-30 | 科里克萨有限公司 | 用于治疗及诊断衣原体感染的化合物和方法 |
| US6565856B1 (en) | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| US6808713B1 (en) | 1998-12-28 | 2004-10-26 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| GB9902555D0 (en) | 1999-02-05 | 1999-03-24 | Neutec Pharma Plc | Medicament |
| WO2000066739A2 (en) | 1999-05-03 | 2000-11-09 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| CA2385325C (en) | 1999-09-20 | 2012-04-10 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| US6632663B1 (en) | 1999-09-22 | 2003-10-14 | Aventis Pasteur Limited | DNA immunization against chlamydia infection |
| EP1255783B1 (de) * | 1999-12-15 | 2005-12-07 | Univation Technologies LLC | Polymerisationsverfahren |
| EP1240331B1 (de) | 1999-12-22 | 2010-04-07 | Aventis Pasteur Limited | Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen |
| AU2138501A (en) | 1999-12-22 | 2001-07-03 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| EP1275704B1 (de) * | 2000-04-03 | 2006-09-06 | MITSUBISHI PENCIL Co., Ltd. | Ölhaltige kugelschreibertinte und kugelschreiber |
| US20020071831A1 (en) | 2000-04-04 | 2002-06-13 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US20030100706A1 (en) | 2000-04-04 | 2003-05-29 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US20020082402A1 (en) | 2000-04-04 | 2002-06-27 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US20020094965A1 (en) | 2000-04-04 | 2002-07-18 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US20020132994A1 (en) | 2000-04-04 | 2002-09-19 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| AU2001255596A1 (en) | 2000-04-21 | 2001-11-07 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| EP1282718B1 (de) | 2000-05-08 | 2006-12-20 | Sanofi Pasteur Limited | Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen |
| US20040254130A1 (en) | 2000-05-08 | 2004-12-16 | Murdin Andrew D | Chlamydia antigens and corresponding dna fragments and uses thereof |
| ATE440861T1 (de) | 2000-07-03 | 2009-09-15 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia pneumoniae |
| US6706274B2 (en) | 2001-01-18 | 2004-03-16 | Scimed Life Systems, Inc. | Differential delivery of nitric oxide |
| US7061245B2 (en) * | 2004-02-06 | 2006-06-13 | Snap-On Incorporated | Coil-on plug capacitive sensors and passive coil-on plug diagnostic system incorporating same |
-
2000
- 2000-03-09 EP EP08004636A patent/EP2172214A3/de not_active Withdrawn
- 2000-03-09 EP EP00908862A patent/EP1163342B1/de not_active Expired - Lifetime
- 2000-03-09 DE DE60041042T patent/DE60041042D1/de not_active Expired - Lifetime
- 2000-03-09 CA CA2365196A patent/CA2365196C/en not_active Expired - Fee Related
- 2000-03-09 NZ NZ514140A patent/NZ514140A/en not_active IP Right Cessation
- 2000-03-09 MX MXPA01009256A patent/MXPA01009256A/es unknown
- 2000-03-09 AU AU31383/00A patent/AU775695B2/en not_active Ceased
- 2000-03-09 AT AT00908862T patent/ATE417106T1/de active
- 2000-03-09 JP JP2000605744A patent/JP4832646B2/ja not_active Expired - Fee Related
- 2000-03-09 WO PCT/CA2000/000240 patent/WO2000055326A1/en not_active Ceased
-
2004
- 2004-11-01 US US10/976,917 patent/US7183402B2/en not_active Expired - Fee Related
-
2005
- 2005-04-18 US US11/107,823 patent/US7285276B2/en not_active Expired - Fee Related
-
2007
- 2007-09-11 US US11/898,220 patent/US7629327B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4832646B2 (ja) | 2011-12-07 |
| CA2365196C (en) | 2011-11-15 |
| MXPA01009256A (es) | 2003-07-14 |
| AU775695B2 (en) | 2004-08-12 |
| US7183402B2 (en) | 2007-02-27 |
| US7285276B2 (en) | 2007-10-23 |
| EP1163342B1 (de) | 2008-12-10 |
| US20050069942A1 (en) | 2005-03-31 |
| JP2002538825A (ja) | 2002-11-19 |
| US7629327B2 (en) | 2009-12-08 |
| AU3138300A (en) | 2000-10-04 |
| US20080113933A1 (en) | 2008-05-15 |
| CA2365196A1 (en) | 2000-09-21 |
| US20050186266A1 (en) | 2005-08-25 |
| NZ514140A (en) | 2001-09-28 |
| EP1163342A1 (de) | 2001-12-19 |
| DE60041042D1 (de) | 2009-01-22 |
| WO2000055326A1 (en) | 2000-09-21 |
| EP2172214A2 (de) | 2010-04-07 |
| EP2172214A3 (de) | 2011-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000066739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001046224A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001070174A3 (en) | Vegf-modulated genes and methods employing them | |
| ATE384793T1 (de) | Chlamydia antigene und entsprechende dna- fragmente und ihre verwendungen | |
| DE60144201D1 (de) | Lawsonia intracellularis Impfstoff | |
| ATE348892T1 (de) | Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen | |
| WO2001046225A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| DE60041042D1 (de) | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon | |
| WO2001075112A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001075111A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001075113A3 (en) | Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof | |
| WO2001074863A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001075114A3 (en) | Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof | |
| WO2001046226A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2000006742A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| MXPA01004353A (es) | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. | |
| WO2000026239A3 (en) | $i(chlamydia) antigens and corresponding dna fragments and uses thereof | |
| WO2000011183A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| DE69925927D1 (de) | Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung | |
| WO2001036455A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2000006743A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2000006739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| ATE384738T1 (de) | Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen | |
| WO2001036457A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001036456A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1163342 Country of ref document: EP |